Vdrive Evaluation of Remote Steering and Testing in Lasso Electrophysiology Procedures Study (VERSATILE)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This study will evaluate the use of a robotic device that is remotely controlled to maneuver a circular mapping catheter in the left atrium during Atrial Fibrillation (AF) ablation procedures.
| Condition | Intervention | Phase |
|---|---|---|
|
Atrial Fibrillation, Magnetic Navigation, Robotic Control, RMT ThermoCool Catheter |
Device: Vdrive Lasso navigation Procedure: Manual Lasso navigation |
Phase 3 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Vdrive Evaluation of Remote Steering and Testing in Lasso Electrophysiology Procedures Study |
- Safety outcome to be assessed by comparing the rate of serious adverse events within 7 days of the procedure between both the control and the investigational device groups. [ Time Frame: Within 7 days of the procedure ] [ Designated as safety issue: Yes ]The Vdrive will allow physicians to manipulate compatible circular mapping catheters while maintaining a safety profile that is not inferior to manual circular catheter navigation.
| Estimated Enrollment: | 120 |
| Study Start Date: | August 2012 |
| Estimated Study Completion Date: | October 2013 |
| Estimated Primary Completion Date: | October 2013 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: Manual Lasso navigation
Use of conventional manual navigation techniques with the Lasso catheter
|
Procedure: Manual Lasso navigation
Manually maneuver a Lasso catheter
|
|
Experimental: Vdrive Lasso navigation
Use of the Vdrive to remotely and robotically control the manipulation of a Lasso catheter
|
Device: Vdrive Lasso navigation
Remote robotic Lasso navigation
|
Detailed Description:
Key to the success of an electrophysiology procedure is the ability to accurately map, sense and pace the heart. Electrophysiology mapping catheters are available in a variety of shapes and electrode configurations. The majority of these catheters are manipulated manually by the physician. The Vdrive simplifies these manipulations by allowing an operator to mechanically advance, retract, rotate, deflect and maneuver a circular mapping catheter. The circular mapping catheter is not altered in structure, function or indication in the same manner as the predicate device (Cardiodrive Catheter Advancement System).
This is a prospective, randomized, non-blinded, controlled study comparing manual navigation of a circular mapping catheter with mechanical navigation by the Vdrive. A total of 120 patients are expected to complete the study: 80 patients in the Vdrive navigation arm and 40 patients in the manual navigation arm. Patients will be enrolled at a minimum of one site in the European Union where the product is currently marketed and the United States, where the Vdrive is considered to be investigational.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Left atrial AF ablation procedure requiring the use of a Lasso mapping catheter
- Subject must be at least 18 years of age
- Subject must be male, female of no childbearing potential, or a female that has a negative pregnancy test prior to randomization
Exclusion Criteria:
- Unable to safely expose subject to a magnetic field
- Prior AF ablation procedure
- Patients with fewer than 4 PVs are excluded
- Patients with persistent AF in whom early recurrence of AF following cardioversion would preclude completion of the pacing maneuvers described in the protocol or patients with other conditions that would similarly preclude completion of the pacing maneuvers
- Contraindication to procedure or unable to return for follow-up
- History of clotting disorder, bleeding abnormalities or contraindication to anticoagulation
- Actively participating in other cardiac device trial(s)
- Currently pregnant
- Under 18 years of age
- Prosthetic valves
- Atrial abnormalities (thrombus, myxoma or baffle)
- Other exclusions per the investigator
Contacts and Locations| Contact: Qun Sha, MD | (314) 678-6143 | qun.sha@stereotaxis.com |
| United States, Kentucky | |
| Central Baptist Hospital | Recruiting |
| Lexington, Kentucky, United States, 40503 | |
| Contact: Laura Martin 859-260-4145 laura.martin@bhsi.com | |
| Principal Investigator: Gery Tomassoni, MD | |
| United States, Texas | |
| Texas Cardiac Arrhythmia Institute | Recruiting |
| Austin, Texas, United States, 78705 | |
| Contact: Debbie Cardinal 512-458-9410 dscardinal@austinheartbeat.com | |
| Principal Investigator: David Burkhardt, MD | |
| Baylor Research Institute | Recruiting |
| Dallas, Texas, United States, 75204 | |
| Contact: Natalie Settele 469-814-4712 natalie.settele@baylorhealth.edu | |
| Principal Investigator: J Brian Deville, M.D. | |
| Belgium | |
| ZNA Campus Middelheim Lindendreef 1 | Recruiting |
| Antwerpen, Belgium, 2020 | |
| Contact: Christine Jacobs, RN 003232803221 Nancy.Aerts@zna.be | |
| Principal Investigator: Bruno Schwagten, MD | |
| Germany | |
| IKFE HDZ GbmH | Recruiting |
| Bad Oeynhausen, Germany, 32545 | |
| Contact: Georg Nölker, MD 49-(0) 5731-97-0 GNoelker@hdz-nrw.de | |
| Principal Investigator: Georg Nölker, MD | |
| Study Director: | Qun Sha, MD | Stereotaxis Inc |
More Information
No publications provided
| Responsible Party: | Stereotaxis |
| ClinicalTrials.gov Identifier: | NCT01656772 History of Changes |
| Other Study ID Numbers: | CLIN-020 |
| Study First Received: | July 30, 2012 |
| Last Updated: | April 10, 2013 |
| Health Authority: | United States: Food and Drug Administration |
Additional relevant MeSH terms:
|
Atrial Fibrillation Arrhythmias, Cardiac Heart Diseases Cardiovascular Diseases Pathologic Processes |
ClinicalTrials.gov processed this record on May 19, 2013